Life Science Investing PharmaTher Advances Ketamine Patch as Non-Opioid Pain Relief Solution Leveraging FDA Approved IV Ketamine ), Aligned with FDA's CNPV National Priority Initiative 27 August
Life Science Investing PharmaTher Advances Ketamine Patch as Non-Opioid Pain Relief Solution Leveraging FDA Approved IV Ketamine ), Aligned with FDA's CNPV National Priority Initiative 27 August
Life Science Investing PharmaTher Provides Corporate Update Following FDA Approval of Ketamine ) 26 August
